EQUBITS Licenses Foresight to Novartis and Johnson and Johnson
News Nov 01, 2005
EQUBITS have announced the first customers of their flagship product, EQUBITS Foresight. Customers include Novartis, Johnson and Johnson PRD, and BASF.
"After extensive testing and validation, customers are purchasing EQUBITS Foresight as an easy-to-use software solution for their data mining problems. Our customers expect a lot from new software and, as a result, evaluated and tested Equbits Foresight rigorously. By outperforming existing methods in customer evaluations, EQUBITS has established itself as a best in class, accurate, interpretable predictive modeling solution provider," says Ravi Mallela, VP of Marketing, EQUBITS LLC.
EQUBITS Foresight is being used to solve complex predictive modeling problems in the High Throughput Screening and ADME-Tox environments.
By applying EQUBITS Foresight to challenging predictive modeling problems, customers are generating more accurate, interpretable results.
"Equbits provides customers with data mining solutions that combine the accuracy of non-linear modeling with a level of interpretability provided by linear models," says Dr. Mallela.
XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery ServicesNews
XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK.READ MORE
BioAscent Establishes Integrated Drug Discovery Services OfferingNews
Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences.READ MORE
Lab Innovations returns to the NEC, Bimingham , UKNews
Save the date for the UK’s only lab-dedicated exhibition showcase!READ MORE
Comments | 0 ADD COMMENT
International Conference on Biobetters and Regulatory Affairs
Jun 27 - Jun 28, 2018